68382-0914 Erlotinib - CanMED: NDC

Product NDC:

68382-0914

Brand Name:

Erlotinib

Generic Name:

Erlotinib

Dosage Form Name:

TABLET

Administration Route:

Oral

Substances:

Name: ERLOTINIB HYDROCHLORIDE

Strength: 100.0

Unit: mg/1

Packages:

Code: 68382-0914-06

Description: 30 TABLET in 1 BOTTLE (68382-914-06)

Effective Date: April 30, 2020

Discontinued:

Code: 68382-0914-16

Description: 90 TABLET in 1 BOTTLE (68382-914-16)

Effective Date: April 30, 2020

Discontinued:

Code: 68382-0914-84

Description: 3 BLISTER PACK in 1 CARTON (68382-914-84) / 10 TABLET in 1 BLISTER PACK (68382-914-30)

Effective Date: April 30, 2020

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

EGFR

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox